Antifungals Global Market Report 2025

Description

Antifungal drugs are pharmaceuticals designed to detect and eradicate fungal pathogens, particularly in conditions arising from unsanitary environments. These medications, also referred to as antimycotic drugs, serve to treat and prevent fungal infections like athlete's foot, ringworm, candidiasis (thrush), and more severe systemic conditions such as cryptococcal meningitis.

The primary categories of antifungal drugs include echinocandins, azoles, polyenes, and allylamines. Echinocandins represent a novel class of antifungal medications that operate by specifically inhibiting the formation of 1,3-D-glucan, a crucial component of the fungal cell wall. Antifungals can be administered through various routes, including oral, parenteral, and topical methods, and they cater to therapeutic indications such as aspergillosis, dermatophytosis, candidiasis, among others. These drugs find applications in various sectors, including hospitals and clinics, dermatology clinics, and other user groups.

The antifungals market research report is one of a series of new reports from The Business Research Company that provides antifungals market statistics, including antifungals industry global market size, regional shares, competitors with antifungals market share, detailed antifungals market segments, market trends, and opportunities, and any further data you may need to thrive in the antifungals industry. This antifungals market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The antifungals market size has grown strongly in recent years. It will grow from $27.01 billion in 2024 to $29.67 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to fungal disease prevalence, aging population, healthcare infrastructure, awareness and education.

The antifungals market size is expected to see strong growth in the next few years. It will grow to $41.84 billion in 2029 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to emerging fungal strains, regulatory approvals, global health concerns, increased healthcare spending, patient education and awareness. Major trends in the forecast period include research and development, telemedicine and e-health, advancements in antifungal drug development, collaborations and partnerships.

The growing prevalence of fungal infections is expected to drive the growth of the antifungals market in the coming years. Fungal infections are diseases caused by the invasion and growth of fungi in or on the body. Fungi can affect various body parts, including the skin, nails, lungs, and mucous membranes. The rise in fungal infections is attributed to factors such as the increasing number of immunocompromised individuals, climate change creating more favorable environments for fungal growth, greater use of broad-spectrum antibiotics disrupting natural microbiomes, poor hygiene, urbanization, and the growing prevalence of chronic conditions like diabetes, which make individuals more susceptible to fungal infections. Antifungals are vital in treating fungal diseases by inhibiting the growth and reproduction of fungi, either by disrupting their cell wall or membrane, blocking essential enzymatic processes, or interfering with their ability to synthesize vital components, thus reducing fungal load, alleviating symptoms, and preventing the spread of infection. For instance, in September 2024, the International Society for Infectious Diseases, a US-based non-profit organization, reported an annual incidence of 6.5 million invasive fungal infections, leading to approximately 3.8 million deaths, with 2.5 million (68%; range 35-90%) directly attributable to these infections. As a result, the increasing occurrence of fungal infections is anticipated to fuel the growth of the antifungals market.

The expansion of healthcare infrastructure is expected to drive the growth of the antifungals market. Healthcare infrastructure includes the physical and organizational structures, facilities, and systems that facilitate the delivery of healthcare services. It encompasses the essential facilities, systems, and resources required for the effective management of fungal infections. For example, in May 2023, according to the Office for National Statistics, a UK-based government body, the healthcare spending in the UK reached approximately $347.74 billion in 2022, reflecting a nominal increase of 0.7% compared to the previous year. This investment in healthcare infrastructure is anticipated to play a significant role in propelling the growth of the antifungals market in the future.

Drug developers and manufacturers in the anti-infective drugs market are increasingly focusing on expanding their operations by strengthening various departments, including research and development, marketing, and manufacturing. They are achieving this through collaborative efforts and strategic partnerships with other companies and research institutes. These collaborations enable them to diversify their product portfolios and stay competitive in the market while increasing their revenues. Therefore, companies operating in the anti-infective drugs market should seriously consider the potential benefits of strategic collaborations. Such partnerships can help them broaden their product offerings, enhance their market presence, and ultimately drive higher revenues, ensuring their continued competitiveness in the market.

Major companies in the antifungals market are actively involved in product innovation to enhance their profitability. One notable innovation is the development of Supra Bioavailable Itraconazole, an advanced formulation of the antifungal medication itraconazole aimed at improving its bioavailability and efficacy in the treatment of fungal infections. For example, in June 2022, Apex Labs, an India-based pharmaceutical company, introduced Supra Bioavailable Itraconazole in 65 and 130 mg capsules. These capsules deliver a higher proportion (90 percent) of the active medication to the body's biological system, necessitating lower dosages. This reduction in inter-individual variability holds the potential for enhanced effectiveness in the treatment of fungal infections. Such innovations play a crucial role in strengthening a company's position and profitability in the antifungals market.

Major companies operating in the antifungals market include Pfizer Inc., Novartis International AG, Merck & Co. Inc., Bayer AG, Abbott Laboratories, Sanofi S.A., Kramer Laboratories Inc., GlaxoSmithKline PLC, Gilead Sciences Inc., Basilea Pharmaceutica AG, Sigma-Aldrich, Astellas Pharma Inc., Janssen Pharmaceutica NV, Zydus Cadila Healthcare Ltd., Teva Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries Ltd., Sumitomo Dainippon Pharma Co. Ltd., Scynexis Inc., Mayne Pharma Inc., Cosmo Pharmaceuticals NV, Leadiant Biosciences Inc., Glenmark Pharmaceuticals Limited, Cidara Therapeutics, MATINAS BIOPHARMA, Mylan N.V., Perrigo Company PLC, Wockhardt Ltd., Lupin Limited, Dr. Reddy's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Hikma Pharmaceuticals PLC, Mayne Pharma Group Limited, Fresenius Kabi AG, Baxter International Inc., Akorn Operating Company LLC, Amphastar Pharmaceuticals Inc., Mylan Institutional LLC, West-Ward Pharmaceuticals Corp., Gland Pharma Limited, Aurobindo Pharma Limited

North America was the largest region in the drugs for antifungals market in 2024. The Middle East is expected to be the fastest-growing region in the antifungals market. The regions covered in the antifungals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the antifungals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The antifungal market consists of sales of clotrimazole, miconazole, and ketoconazole. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Antifungals Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on antifungals market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for antifungals ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The antifungals market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Drug Type: Echinocandins; Azoles; Polyenes; Allylamines
2) By Route of Administration: Oral; Parenteral; Topical
3) By End users: Hospitals & Clinics; Dermatology clinics; Other Users

Subsegments

1) By Echinocandins: Caspofungin; Micafungin; Anidulafungin
2) By Azoles: Fluconazole; Itraconazole; Voriconazole; Posaconazole; Ketoconazole
3) By Polyenes: Amphotericin B; Nystatin
4) By Allylamines: Terbinafine; Naftifine
Companies Mentioned: Pfizer Inc.; Novartis International AG; Merck & Co. Inc.; Bayer AG; Abbott Laboratories
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.

Product Code: r32384

1. Executive Summary

2. Antifungals Market Characteristics

3. Antifungals Market Trends And Strategies

4. Antifungals Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Antifungals Growth Analysis And Strategic Analysis Framework

5.1. Global Antifungals PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Antifungals Market Growth Rate Analysis
5.4. Global Antifungals Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Antifungals Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Antifungals Total Addressable Market (TAM)

6. Antifungals Market Segmentation

6.1. Global Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Echinocandins
Azoles
Polyenes
Allylamines
6.2. Global Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral
Parenteral
Topical
6.3. Global Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals & Clinics
Dermatology Clinics
Other Users
6.4. Global Antifungals Market, Sub-Segmentation Of Echinocandins, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Caspofungin
Micafungin
Anidulafungin
6.5. Global Antifungals Market, Sub-Segmentation Of Azoles, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluconazole
Itraconazole
Voriconazole
Posaconazole
Ketoconazole
6.6. Global Antifungals Market, Sub-Segmentation Of Polyenes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Amphotericin B
Nystatin
6.7. Global Antifungals Market, Sub-Segmentation Of Allylamines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Terbinafine
Naftifine

7. Antifungals Market Regional And Country Analysis

7.1. Global Antifungals Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Antifungals Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Antifungals Market

8.1. Asia-Pacific Antifungals Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Antifungals Market

9.1. China Antifungals Market Overview
9.2. China Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Antifungals Market

10.1. India Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Antifungals Market

11.1. Japan Antifungals Market Overview
11.2. Japan Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Antifungals Market

12.1. Australia Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Antifungals Market

13.1. Indonesia Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Antifungals Market

14.1. South Korea Antifungals Market Overview
14.2. South Korea Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Antifungals Market

15.1. Western Europe Antifungals Market Overview
15.2. Western Europe Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Antifungals Market

16.1. UK Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Antifungals Market

17.1. Germany Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Antifungals Market

18.1. France Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Antifungals Market

19.1. Italy Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Antifungals Market

20.1. Spain Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Antifungals Market

21.1. Eastern Europe Antifungals Market Overview
21.2. Eastern Europe Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Antifungals Market

22.1. Russia Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Antifungals Market

23.1. North America Antifungals Market Overview
23.2. North America Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Antifungals Market

24.1. USA Antifungals Market Overview
24.2. USA Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Antifungals Market

25.1. Canada Antifungals Market Overview
25.2. Canada Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Antifungals Market

26.1. South America Antifungals Market Overview
26.2. South America Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Antifungals Market

27.1. Brazil Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Antifungals Market

28.1. Middle East Antifungals Market Overview
28.2. Middle East Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Antifungals Market

29.1. Africa Antifungals Market Overview
29.2. Africa Antifungals Market, Segmentation By Drug Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Antifungals Market, Segmentation By Route of Administration, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Antifungals Market, Segmentation By End Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Antifungals Market Competitive Landscape And Company Profiles

30.1. Antifungals Market Competitive Landscape
30.2. Antifungals Market Company Profiles
- 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Novartis International AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis

31. Antifungals Market Other Major And Innovative Companies

31.1. Sanofi S.A.
31.2. Kramer Laboratories Inc.
31.3. GlaxoSmithKline plc
31.4. Gilead Sciences Inc.
31.5. Basilea Pharmaceutica AG
31.6. Sigma-Aldrich
31.7. Astellas Pharma Inc.
31.8. Janssen Pharmaceutica NV
31.9. Zydus Cadila Healthcare Ltd.
31.10. Teva Pharmaceutical Industries Ltd.
31.11. Sun Pharmaceutical Industries Ltd.
31.12. Sumitomo Dainippon Pharma Co. Ltd.
31.13. Scynexis Inc.
31.14. Mayne Pharma Inc.
31.15. Cosmo Pharmaceuticals NV

32. Global Antifungals Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Antifungals Market

34. Recent Developments In The Antifungals Market

35. Antifungals Market High Potential Countries, Segments and Strategies

35.1 Antifungals Market In 2029 - Countries Offering Most New Opportunities
35.2 Antifungals Market In 2029 - Segments Offering Most New Opportunities
35.3 Antifungals Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer